Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed May 10, 2024 · 10-Q · 40 days after period end · 0001437749-24-016040
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | $25.04M | -$24.27M | -$17.53M | -$3.53M |
| EPS Diluted | -$0.43 | -$0.58 | -$0.44 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 10, 2024 · 40 d after period end
